5 March, 2026
JUVE Patent ranks Plasseraud IP as one of France's top patent attorneys.
Within the Plasseraud IP group, JUVE Patent lists three of our partners as (...)
26 February, 2026
Plasseraud IP is shortlisted in several categories at the Managing IP EMEA Awards 2026, to be held on May 1st , 2026.
Each year, Managing IP (MIP) (...)
29 January, 2026
On 4 November 2025 in London, intellectual property professionals gathered to mark IP Inclusive’s 10th anniversary and underscore that Equity, (...)
6 February, 2026
The Pharma & Biotech Patent Litigation Europe conference will take place from January 19 to 21, 2026, in Amsterdam.
Our partners Ina Schreiber, (...)
20 November, 2025
This investment will enable the company to finalize the technical development of its solution and accelerate the industrialization of its production (...)
6 November, 2025
Founded in 2021, Genomines is a deeptech startup that uses biotechnology to reinvent the mining industry.
This funding will enable Genomines to (...)
4 November, 2025
Guylène Kiesel Le Cosquer
Our experts, Guylène Kiesel Le Cosquer, Partner and Board Member, and Ina Schreiber, Partner and Head of the Patent Department, represent Plasseraud (...)
5 November, 2025
On October 22, 2025, the biopharmaceutical group Ipsen announced that it had entered into a definitive agreement to acquire ImCheck Therapeutics, a (...)
5 November, 2025
Plasseraud IP is proud to announce that Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud, and Ina Schreiber have once again been ranked among the best (...)
5 November, 2025
Plasseraud IP is proud to announce that Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud, and Ina Schreiber have once again been ranked among the best (...)